Peer review reports
From: Loss of PDPK1 abrogates resistance to gemcitabine in label-retaining pancreatic cancer cells
Original Submission | ||
---|---|---|
11 Jun 2018 | Submitted | Original manuscript |
12 Jul 2018 | Author responded | Author comments - Dandan Li |
Resubmission - Version 2 | ||
12 Jul 2018 | Submitted | Manuscript version 2 |
Publishing | ||
23 Jul 2018 | Editorially accepted | |
31 Jul 2018 | Article published | 10.1186/s12885-018-4690-1 |